Morocco’s Laprophan Makes History with First European Acquisition, Taking Control of Swiss Rivopharm
Morocco’s Laprophan pharmaceutical group has finalized the acquisition of a majority stake in Rivopharm, a Swiss company specializing in specialty medicines, complex pharmaceutical formulations and high-value regulatory expertise, reported medias24. The deal, completed on June 17, marks Laprophan’s first European acquisition and what its president describes as a historic milestone for Moroccan pharmaceutical industry on […]































